绝经是乳腺芳香化酶表达的决定因素及其与体重指数、炎症和全身标志物的关联
这项横断面研究纳入102例绝经前和59例绝经后因乳腺癌治疗或预防行乳房切除术的女性,发现绝经后女性乳腺芳香化酶水平更高,且与体重指数、白色脂肪组织炎症及全身代谢标志物相关,提示脂肪功能障碍背景下芳香化酶升高可能是绝经后肥胖女性激素依赖性乳腺癌发病率较高的机制。
要点
- 绝经后女性体重指数更高、乳腺白色脂肪组织炎症更重,且乳腺芳香化酶水平高于绝经前女性。
- 体重指数在绝经前和绝经后女性中均与乳腺芳香化酶信使RNA正相关。
- 绝经后女性中脂肪细胞直径及瘦素、高敏C反应蛋白、脂联素和高密度脂蛋白胆固醇与芳香化酶的关联强于绝经前女性。
核心结论
- 脂肪功能障碍背景下芳香化酶升高,为绝经后肥胖女性激素依赖性乳腺癌发病率较高提供了可能的机制。
研究设计与样本
- 横断面研究,纳入102例绝经前(年龄27至56岁)和59例绝经后(年龄45至74岁)因乳腺癌治疗或预防行乳房切除术的女性。
主要发现
- 绝经后女性体重指数高于绝经前女性,乳腺白色脂肪组织炎症多于绝经前女性。
- 绝经后组空腹白细胞介素-6、葡萄糖、瘦素、高敏C反应蛋白和稳态模型评估2胰岛素抵抗评分高于绝经前组。
- 体重指数在绝经前和绝经后女性中均与乳腺芳香化酶信使RNA正相关。
- 绝经后女性乳腺组织中芳香化酶水平高于绝经前女性,且在炎症与非炎症组织中均更高,独立于体重指数。
- 脂肪细胞直径及瘦素、高敏C反应蛋白、脂联素和高密度脂蛋白胆固醇水平与芳香化酶的关联在绝经后女性中强于绝经前女性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Most estrogen-dependent breast cancers occur after menopause, despite low levels of circulating estrogens. Breast expression of the estrogen-biosynthetic enzyme, aromatase, is proposed to drive breast cancer development after menopause. However, the effects of menopause on breast aromatase expression are unknown. OBJECTIVE: To determine the effect of menopause on breast aromatase expression in relation to body mass index (BMI), white adipose tissue inflammation (WATi), and systemic markers of metabolic dysfunction. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 102 premenopausal (age 27 to 56) and 59 postmenopausal (age 45 to 74) women who underwent mastectomy for breast cancer treatment/prevention. OUTCOME: Breast tissue was assessed for the presence of crown-like structures and the expression and activity of aromatase. Systemic markers examined include interleukin (IL)-6, insulin, glucose, leptin, adiponectin, high-sensitivity C-reactive protein (hsCRP), cholesterol, and triglycerides. Multivariable analysis was performed for aromatase messenger RNA (mRNA) in relation to BMI, WATi, and blood markers. RESULTS: Postmenopausal women had higher BMI and more breast WATi than premenopausal women. Fasting levels of IL-6, glucose, leptin, hsCRP, and homeostatic model assessment 2 insulin resistance score were higher in the postmenopausal group. BMI was positively correlated with aromatase mRNA in both pre- and postmenopausal women. Aromatase levels were higher in breast tissue of postmenopausal women, with levels being higher in inflamed vs noninflamed, independent of BMI. Adipocyte diameter and levels of leptin, hsCRP, adiponectin, and high-density lipoprotein cholesterol were more strongly correlated with aromatase in postmenopausal than premenopausal women. CONCLUSIONS: Elevated aromatase in the setting of adipose dysfunction provides a possible mechanism for the higher incidence of hormone-dependent breast cancer in obese women after menopause.
引用
- Brown KA, Iyengar NM, Zhou XK, et al. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers. J Clin Endocrinol Metab. 2017. PMID: 28323914. doi:10.1210/jc.2016-3606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。